Works matching IS 03407004 AND DT 2004 AND VI 53 AND IP 7


Results: 10
    1
    2

    Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein–based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia.

    Published in:
    Cancer Immunology, Immunotherapy, 2004, v. 53, n. 7, p. 642, doi. 10.1007/s00262-004-0501-4
    By:
    • Hallez, Sophie;
    • Simon, Philippe;
    • Maudoux, Frédéric;
    • Doyen, Jean;
    • Noël, Jean-Christophe;
    • Beliard, Aude;
    • Capelle, Xavier;
    • Buxant, Frédéric;
    • Fayt, Isabelle;
    • Lagrost, Anne-Cécile;
    • Hubert, Pascale;
    • Gerday, Colette;
    • Burny, Arsène;
    • Boniver, Jacques;
    • Foidart, Jean-Michel;
    • Delvenne, Philippe;
    • Jacobs, Nathalie
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone.

    Published in:
    Cancer Immunology, Immunotherapy, 2004, v. 53, n. 7, p. 617, doi. 10.1007/s00262-003-0498-0
    By:
    • Nakajima, Hiroko;
    • Kawasaki, Kotomi;
    • Oka, Yoshihiro;
    • Tsuboi, Akihiro;
    • Kawakami, Manabu;
    • Ikegame, Kazuhiro;
    • Hoshida, Yoshihiko;
    • Fujiki, Fumihiro;
    • Nakano, Akiko;
    • Masuda, Tomoki;
    • Wu, Fei;
    • Taniguchi, Yuki;
    • Yoshihara, Satoshi;
    • Elisseeva, Olga A.;
    • Oji, Yusuke;
    • Ogawa, Hiroyasu;
    • Azuma, Ichiro;
    • Kawase, Ichiro;
    • Aozasa, Katsuyuki;
    • Sugiyama, Haruo
    Publication type:
    Article
    10